BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
40 hedge funds and large institutions have $31K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
843% more capital inflows, than outflows
Capital inflows: $2.82K | Capital outflows: $299
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0% more funds holding
Funds holding: 40 → 40 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.04K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$744 |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$38 |
| 4 |
IFP Advisors
Tampa,
Florida
|
+$2 |
| 5 |
Chicago Partners Investment Group
Chicago,
Illinois
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$216 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$64 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$19 |
BTX.WS Hedge Fund Activity: Q2 2018 in Review
40 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q2 2018, worth a combined $31K — down 39% from $51.1K a quarter earlier.
Fund positioning in BTX.WS was balanced in Q2 2018: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.04K. The largest seller was UBS Group, cutting an estimated $216.
- 40 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $31K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q2 2018, down 39% quarter-over-quarter.
- 2 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q2 2018 and 2 closed out, a net change of 0 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q2 2018 was Susquehanna International Group, an estimated $2.04K added.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q2 2018 was UBS Group, an estimated $216 sold.
Based on aggregated 13F filings for Q2 2018.